# Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neutrophil-lymphocyte-ratio-as-a-predictive-biomarker-for-response-to-high-dose/

## Facts

| Field | Value |
| --- | --- |
| Author Names | James A. Kuzman,David D. Stenehjem,Joseph A. Merriman,Archana M. Agarwal,Shiven B. Patel,Andrew W. Hahn,Anitha Alex,Dan Albertson,David Gill,Neeraj Agarwal |
| Citations | 48 |
| DOI | 10.1186/s12894-016-0192-0 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmcurol.biomedcentral.com/counter/pdf/10.1186/s12894-016-0192-0 |
| OpenAlex ID | https://openalex.org/W2570785250 |
| PMID | 28056941 |
| Type | article |
| Year | 2017 |

## Paper authors

- [David D. Stenehjem](https://scholariq.org/researchers/david-d-stenehjem/)

## Paper primary topic

- [Inflammatory Biomarkers in Disease Prognosis](https://scholariq.org/topics/inflammatory-biomarkers-in-disease-prognosis/)

## Paper topics

- [Inflammatory Biomarkers in Disease Prognosis](https://scholariq.org/topics/inflammatory-biomarkers-in-disease-prognosis/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Multiple and Secondary Primary Cancers](https://scholariq.org/topics/multiple-and-secondary-primary-cancers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.